STOCK TITAN

Lantheus Holdings Inc - LNTH STOCK NEWS

Welcome to our dedicated news page for Lantheus Holdings (Ticker: LNTH), a resource for investors and traders seeking the latest updates and insights on Lantheus Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Lantheus Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Lantheus Holdings's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.1%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.83%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.99%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.91%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.95%
Tags
clinical trial
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.91%
Tags
clinical trial
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.13%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.06%
Tags
conferences earnings
Lantheus Holdings Inc

Nasdaq:LNTH

LNTH Rankings

LNTH Stock Data

4.14B
67.11M
2.53%
104.62%
7.62%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
North Billerica

About LNTH

lantheus holdings, inc. (nasdaq: lnth) is the parent company of lantheus medical imaging, inc. (lmi), which is a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. lmi provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. lmi’s key products include the echocardiography contrast agent definity® vial for (perflutren lipid microsphere) injectable suspension; technelite® (technetium tc99m generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and xenon (xenon xe 133 gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs. the company is headquartered in north billerica, massachusetts with offices in puerto rico and canada. for more information, visit www.lantheus.com.